PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 101 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,006,952 | +35.8% | 1,971,241 | 0.0% | 3.27% | +163.0% |
| Q4 2022 | $3,686,221 | -27.2% | 1,971,241 | 0.0% | 1.24% | -33.0% |
| Q3 2022 | $5,066,000 | +33.2% | 1,971,241 | 0.0% | 1.86% | +52.8% |
| Q2 2022 | $3,804,000 | -35.0% | 1,971,241 | 0.0% | 1.21% | +1.3% |
| Q1 2022 | $5,855,000 | -33.8% | 1,971,241 | 0.0% | 1.20% | -4.2% |
| Q4 2021 | $8,851,000 | -30.1% | 1,971,241 | -24.4% | 1.25% | -12.0% |
| Q3 2021 | $12,669,000 | -28.6% | 2,606,809 | +0.2% | 1.42% | -29.2% |
| Q2 2021 | $17,735,000 | -3.4% | 2,600,410 | 0.0% | 2.01% | +15.5% |
| Q1 2021 | $18,359,000 | +12.8% | 2,600,410 | 0.0% | 1.74% | -28.8% |
| Q4 2020 | $16,279,000 | +15.7% | 2,600,410 | 0.0% | 2.44% | -35.9% |
| Q3 2020 | $14,068,000 | +3.5% | 2,600,410 | -0.1% | 3.81% | +2.4% |
| Q2 2020 | $13,586,000 | +65.9% | 2,602,739 | +0.1% | 3.72% | +9.6% |
| Q1 2020 | $8,191,000 | -21.8% | 2,600,410 | 0.0% | 3.39% | +1.6% |
| Q4 2019 | $10,480,000 | -6.7% | 2,600,410 | 0.0% | 3.34% | -3.8% |
| Q3 2019 | $11,234,000 | +8.3% | 2,600,410 | 0.0% | 3.47% | +31.0% |
| Q2 2019 | $10,376,000 | -62.8% | 2,600,410 | -50.0% | 2.65% | -55.1% |
| Q1 2019 | $27,876,000 | +109.0% | 5,200,820 | +100.0% | 5.89% | -40.4% |
| Q4 2018 | $13,340,000 | -47.1% | 2,600,410 | 0.0% | 9.89% | -17.1% |
| Q3 2018 | $25,224,000 | -4.9% | 2,600,410 | 0.0% | 11.93% | -39.0% |
| Q2 2018 | $26,524,000 | -21.5% | 2,600,410 | 0.0% | 19.57% | -41.1% |
| Q1 2018 | $33,805,000 | -27.4% | 2,600,410 | 0.0% | 33.22% | -1.3% |
| Q4 2017 | $46,547,000 | -28.7% | 2,600,410 | 0.0% | 33.65% | -8.9% |
| Q3 2017 | $65,270,000 | +4.1% | 2,600,410 | 0.0% | 36.93% | -5.6% |
| Q2 2017 | $62,670,000 | +25.2% | 2,600,410 | 0.0% | 39.11% | +20.2% |
| Q1 2017 | $50,058,000 | +25.0% | 2,600,410 | 0.0% | 32.54% | +0.1% |
| Q4 2016 | $40,046,000 | +18.4% | 2,600,410 | 0.0% | 32.50% | +25.8% |
| Q3 2016 | $33,831,000 | -6.5% | 2,600,410 | 0.0% | 25.83% | -3.8% |
| Q2 2016 | $36,172,000 | +11.5% | 2,600,410 | +21.6% | 26.83% | +19.2% |
| Q1 2016 | $32,447,000 | -20.0% | 2,138,872 | 0.0% | 22.51% | -0.3% |
| Q4 2015 | $40,574,000 | -0.2% | 2,138,872 | 0.0% | 22.58% | -1.3% |
| Q3 2015 | $40,639,000 | -26.3% | 2,138,872 | 0.0% | 22.88% | -17.8% |
| Q2 2015 | $55,119,000 | -17.6% | 2,138,872 | 0.0% | 27.83% | -3.7% |
| Q1 2015 | $66,861,000 | -18.9% | 2,138,872 | 0.0% | 28.91% | -23.8% |
| Q4 2014 | $82,454,000 | – | 2,138,872 | – | 37.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|